Core Insights - On September 25, BeiGene's stock rose by 1.93%, with a trading volume of 1.609 billion yuan, indicating positive market sentiment towards the company [1] - The company reported a significant increase in revenue and net profit for the first half of 2025, showcasing strong financial performance [2] Financing and Margin Trading - On September 25, BeiGene had a financing buy-in amount of 190 million yuan, with a net buy of 8.8079 million yuan, indicating robust investor interest [1] - The total margin trading balance for BeiGene reached 1.244 billion yuan, with a financing balance of 1.225 billion yuan, accounting for 3.37% of its market capitalization, which is above the 90th percentile of the past year [1] - The company also experienced high levels of short selling, with a short selling balance of 18.8487 million yuan, also exceeding the 90th percentile of the past year [1] Shareholder Structure - As of June 30, 2025, BeiGene had 23,300 shareholders, a decrease of 3.90% from the previous period, while the average number of circulating shares per person increased by 4.11% to 4,976 shares [2] - The top ten circulating shareholders included notable institutional investors, with changes in holdings reflecting varying levels of confidence in the company [2]
百济神州9月25日获融资买入1.90亿元,融资余额12.25亿元